These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8932503)

  • 1. Progress towards a vaccine for nontypable Haemophilus influenzae.
    St Geme JW
    Ann Med; 1996 Feb; 28(1):31-7. PubMed ID: 8932503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary
    Li W; Zhang X; Yang Y; Yin Q; Wang Y; Li Y; Wang C; Wong SM; Wang Y; Goldfine H; Akerley BJ; Shen H
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7149-E7157. PubMed ID: 29987031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why the rise in Haemophilus influenzae type b infections?
    Silfverdal SA; Bodin L; Olcén P
    Lancet; 2003 Jul; 362(9380):331. PubMed ID: 12892974
    [No Abstract]   [Full Text] [Related]  

  • 6. Modeling the impact of a new vaccine on pneumococcal and nontypable Haemophilus influenzae diseases: a new simulation model.
    De Wals P; Black S; Borrow R; Pearce D
    Clin Ther; 2009 Oct; 31(10):2152-69. PubMed ID: 19922887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why we need a vaccine for non-typeable Haemophilus influenzae.
    Cerquetti M; Giufrè M
    Hum Vaccin Immunother; 2016 Sep; 12(9):2357-61. PubMed ID: 27171854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
    Bamberger EE; Ben-Shimol S; Abu Raya B; Katz A; Givon-Lavi N; Dagan R; Srugo I;
    Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
    Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
    J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the potential of a 48 kDa protein as a vaccine candidate for infection against nontypable Haemophilus influenzae.
    Webb DC; Otczyk DC; Cripps AW
    Vaccine; 2007 May; 25(20):4012-9. PubMed ID: 17379362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemophilus influenzae in chronic bronchitis.
    Murphy TF
    Semin Respir Infect; 2000 Mar; 15(1):41-51. PubMed ID: 10749549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Polysaccharide vaccines against Haemophilus influenzae type B].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1994; 48(1-2):39-44. PubMed ID: 8073141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam.
    Le P; Griffiths UK; Anh DD; Franzini L; Chan W; Swint JM
    Vaccine; 2015 Aug; 33(36):4639-46. PubMed ID: 26044493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for Nontypeable Haemophilus influenzae: the Future Is Now.
    Murphy TF
    Clin Vaccine Immunol; 2015 May; 22(5):459-66. PubMed ID: 25787137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the human immune response to infection.
    Murphy TF; Apicella MA
    Rev Infect Dis; 1987; 9(1):1-15. PubMed ID: 3547567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and prospects for a nontypable Haemophilus influenzae vaccine.
    Barenkamp SJ
    Pediatr Infect Dis J; 2004 May; 23(5):461-2. PubMed ID: 15131472
    [No Abstract]   [Full Text] [Related]  

  • 18. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemophilus influenzae infection and their prevention by vaccination].
    Scholz H; Noack R
    Kinderarztl Prax; 1993 Aug; 61(6):189-91. PubMed ID: 8411843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine.
    Poolman JT; Bakaletz L; Cripps A; Denoel PA; Forsgren A; Kyd J; Lobet Y
    Vaccine; 2000 Dec; 19 Suppl 1():S108-15. PubMed ID: 11163473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.